Emergent BioSolutions is up 16.8%, or $1.16 to $8.04.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on EBS:
- Emergent BioSolutions Stock (NYSE:EBS) Spikes on $704M Ebola Contract
- Emergent BioSolutions awarded 10-year $121M BARDA contract
- Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for Ebola
- Emergent BioSolutions to Release Second Quarter 2023 Financial Results and Conduct Conference Call on August 8, 2023
- EBS Earnings this Week: How Will it Perform?